✦ LIBER ✦

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

✍ Scribed by Michael Dattoli; Kent Wallner; Richard Sorace; John Koval; Jennifer Cash; Rudolph Acosta; Charles Brown; James Etheridge; Michael Binder; Richard Brunelle; Novelle Kirwan; Servando Sanchez; Douglas Stein; Stuart Wasserman

Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 548 KB
Volume: 35
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(96)00214-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1056 Conformal brachytherapy boost to ex

1056 Conformal brachytherapy boost to external beam irradiation for clinically localized high risk prostate cancer

✍ Michael J. Dattoli; Stuart G. Wasserman; John M. Koval; Richard A. Sorace; Jenni 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Long-term outcomes after treatment with

Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma : Influence of prostatic acid phosphatase

✍ Michael Dattoli; Kent Wallner; Lawrence True; Jennifer Cash; Richard Sorace 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to define the long‐term prognostic significance of prostatic acid phosphatase (PAP) levels in patients with higher risk, early‐stage prostate carcinoma. ## METHODS One hundred sixty‐one consecutive patients with Stage T1–T3 prostate carci

Ten-year disease free survival after tra

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma

✍ Haakon Ragde; Abdel-Aziz A. Elgamal; Peter B. Snow; Jeff Brandt; Alfred A. Barto 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

External beam radiation therapy with or

External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma

✍ Yasumasa Nishimura; Yoshishige Okuno; Koji Ono; Michihide Mitsumori; Yasushi Nag 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## BACKGROUND. Clinical results of external beam radiation therapy (RT) with or without intraluminal brachytherapy (IBT) for patients with superficial esophageal carcinoma were evaluated retrospectively. Between 1985 and 1996, 21 patients with superficial esophageal squamous cell carcinoma were tr

Advanced age at diagnosis is an independ

Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma

✍ Anthony V. D'Amico; Kerri Cote; Marian Loffredo; Andrew A. Renshaw; Ming-Hui Che 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Abstract ## BACKGROUND Whether age at diagnosis is predictive of time to prostate carcinoma specific death after external beam radiation therapy (RT) for patients who are diagnosed with clinically localized prostate carcinoma during the prostate specific antigen (PSA) era has not been investiga

Biochemical outcome after radical prosta

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

✍ Anthony V. D'Amico; Richard Whittington; S. Bruce Malkowicz; Kerri Cote; Marian 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative long‐term efficacy of radical prostatectomy (RP) versus conventional‐dose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A